期刊文献+

YC-1改善乏氧增强人肺腺癌A549细胞放射敏感性的体外研究 被引量:2

Effect of YC-1 on improving hypoxia and radiosensitizing human lung adenocarcinoma cells in vitro
原文传递
导出
摘要 目的探讨3-(5’-羟甲基-2’-呋喃基)-1-苯甲基吲唑(YC-1)对乏氧人肺腺癌A蚋细胞的放射增敏作用。方法用噻唑蓝比色法检测YC-1对细胞增殖活性的影响,以及YC-1对细胞作用24h的20%药物抑制浓度(IC20)。细胞克隆形成实验计算细胞存活分数,多靶单击模型拟合细胞存活曲线并计算放射增敏比(SER)。流式细胞仪检测细胞凋亡率和细胞周期。结果YC-1对A舛,细胞有增殖抑制作用,在-定剂量范围内呈时间-剂量依赖性。在常氧和乏氧培养24h下aIC20分别为16.7μmol/L和39.2μmol/L。乏氧加YC-1组的SERD0=1.11,SERDq=1.26。在乏氧培养下,YC-1联合单次2Gy放射能明显促进A549细胞凋亡和G2+M期阻滞[(30.17±1.21)%:(15.44±0.96)%,P=0.000和(21.56±0.47)%:(6.16±0.16)%,P=0.000]。结论YC-1对乏氧的As49细胞有放射增敏作用。 Objective To investigate the radiosensitizing effect of 3- (5'-hydroxy-2'-furyl) -1-benzyl indazole (YC-1) on hypoxic human adenocarcinoma cell line A549. Methods MTT assay was used to test the inhibitory effect of YC-1 on proliferation of A549 cells. Clonogenic assay was performed to determine the radiosensitizing effect of YC-1 on hopxic A549 ceils. Single-hit multi-target model was used to plot survival curve and calculate sensitization enhancement ratio (SER). The cell cycle and apoptosis were measured by flow cytometry. Results The proliferation of A549 ceils was inhibited by YC-1 in a time-dose-dependent manner. In normoxic and hypoxic ceils, the IC20 was 16. 7 μmol/L and 39.2 μmol/L at 24 h, respectively. In the group of hypoxia plus YC-1,SERD0 and SERDq were 1.11 and 1.26, respectively. In hypoxia, YC-1 combined with 2 Gy irradiation could induce cell apoptosis and prolong G2 + M phase arrest ( ( 30.17 ± 1.21)%: (15.44 ±0. 96)% ,P=0. 000;(21.56 ±0. 47)%: (6.16±0. 16)% ,P=0. 000). Conclusions YC-1 could enhance the radiosensitivity of hypoxic A549 ceils.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2012年第4期396-399,共4页 Chinese Journal of Radiation Oncology
基金 江苏省六大人才高峰资助课题(2011-WS-018)
关键词 3-(5’-羟甲基-2’-呋喃基)-1·苯甲基吲唑 放射增敏剂 A粥细胞系 3-(5'-hydroxy-2'-furyl)-l-benzyl indazole Radiosensitivity agents A549 cell line
  • 相关文献

参考文献11

  • 1Vaupel P,Mayer A. Hypoxia in cancer:significance and impact on clinical outcome[J].Cancer and Metastasis Review,2007.225-239.
  • 2Toma-Dasu L,Dasu A,Karlsson M. The relationship between temporal variation of hypoxia,polarographic measurements and predictions of tumour response to radiation[J].Physics in Medicine and Biology,2004.4463-4475.
  • 3Piret JP,Mottet D,Raes M. COCl2,a chemical inducer of hypoxia inducible factor-1,and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2[J].Annals of the New York Academy of Sciences,2002.443-447.
  • 4Brown JM,Giaccia AJ. The unique physiology of solid tumors:opportunities (and problems) for cancer therapy[J].Cancer Research,1998.1408-1416.
  • 5Postovit LM,Adams MA,Lash GE. Oxygen-mediated regulation of tumor cell invasiveness.Involvement of a nitric oxide siginaling pathway[J].Journal of Biological Chemistry,2002.35730-35737.
  • 6Yeo EJ,Chun YS,Cho YS. YC-1:a potential anticancer drug targeting hypoxia-inducible factor 1[J].Journal of the National Cancer Institute,2003.516-525.
  • 7Pan SL,Guh JH,Peng CY. YC-1[3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole]inhabits ndothelial cell functions induced by angiogenic factors in vitro and angiogensis in vivo models[J].Journal of Pharmacology and Experimental Therapeutics,2005.35-42.
  • 8Wang SW,Pan SL,Guh JH. YC-1[3-(5'-Hydroxymethyl-2'-furyl)-l-benzylindazole]exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cells[J].Journal of Pharmacology and Experimental Therapeutics,2005.917-925.
  • 9Huang YT,Pan SL,Guh JH. YC-1 suppresses constitutive nuclear factor-kappa B activation and induces apoptosis in human prostate cancer cells[J].Molecular Cancer Therapeutics,2005.1628-1635.
  • 10Chun YS,Yeo EJ,Park JW. Versatile pharmacoIogical actionsof YC-1:anti-platelet to anticancer[J].Cancer Letters,2004.1-7.

同被引文献8

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部